About HZB Pharma Canada

HZB CMO, a division of HZB Canada,  brings state-of-the-art processes used in our extraction methods, to yield high purity, consistent high quality cannabis oils, extracts and isolates, in industrial-scale quantities. At HZB we offer a wide range of services to the cultivators of cannabis and hemp, and to licensed producers of end products containing oils and extracts.

Our Mission

HZB CMO, a division of HZB Canada,  brings state-of-the-art processes used in our extraction methods, to yield high purity, consistent high quality cannabis oils, extracts and isolates, in industrial-scale quantities. At HZB we offer a wide range of services to the cultivators of cannabis and hemp, and to licensed producers of end products containing oils and extracts.

Executive Team

Mr. Côté held a variety of executive positions at Bell Canada prior to becoming President and Chief Executive Officer of Emergis. Following the acquisition of Emergis by TELUS in January 2008, he was appointed President of TELUS Quebec, TELUS Health and TELUS Ventures. In this role, Mr. Côté was responsible for broadening TELUS Quebec’s presence and driving the company’s national health strategy through timely investments in information technology and innovative wireless solutions. Mr. Côté holds a bachelor’s degree in Industrial Relations from Laval University. In 2007, he was named Entrepreneur of the Year by Ernst & Young, in the Corporate Restructuring category for the province of Quebec. Mr. Côté serves on the boards of Alithya, Aspire Food Group, the Fondation Martin Matte and Purkinje, a Montreal health IT growth company as lead Director. Mr. Côté serves on the Advisor Committee of Groupe Morneau and is also acting as an advisor to different companies’ CEOs.

Mr. Quintal has been a serial entrepreneur since 1990. For more than 30 years, he headed Quintal and Associates, a premier supplier of HR services to the pharmaceutical industry. In 2008 he created Archi- Medic, a company that offers medical coding and transcription services and through the Serenity Nursing division, the company supports chronically ill patients through their virtual health technology. Today, this company has over 160 employees Canada-wide and growing. With more than 30 years in the Canadian Health industry, and a network of pharmaceutical professionals spanning the country, Mr. Quintal has hand chosen and selected a strong group of industry leaders to provide HZB Pharma with the best resources for forging the future of modern medicine.

With more than a decade in commercial cultivation, extraction and processing of the cannabis plant, Mr. Turner is a leader and virtuoso in the field of cannabis as medicinal product. He has operated large scale cultivation, from 160 acres of outdoor production, to creating perpetual growth systems designed to maximize harvest times and resources. His in depth knowledge of commercial scale extraction systems, isolation techniques and isomerization of cannabinoid products makes him an essential part of the team.

Dr Geoffroy was Assistant Professor of Medicine at McGill University before joining the Pharmaceutical Industry, where he held several positions in Montreal, Toronto and Tokyo. Over his more than 20 years in the industry, he has been involved in R&D, Medical Affairs, and Senior Management. In his most recent position at INC, he was involved in Abuse Liability research, testing a diverse array of CNS – active medications, including cannabis products.

Dr Geoffroy has an active clinical practice in Family Medicine, and Geriatrics and is licensed both in Quebec and Ontario. He is a Fellow of the College of Family Physicians of Canada and of the American Society of Addiction Medicine. He is also a Diplomate of the American Board of Addiction Medicine being board-certified in Addiction Medicine.
Dr. Geoffroy has presented at numerous scientific conferences, is well published, and continues to be active in Medical Education.

Alain brings over 20 years of experience in leading finance positions mainly spent with the Diagnostics and Pharmaceutical industries. He was most recently involved with renewable energy and more specifically the wind turbine area being involved with the closing of numerous multi-millions of projects financing. Alain is a business facilitator, driven by start-up creations, with specific experience in team building and strategic development. His analytical skills and his passion for achieving group results will be a key contributor to the commercial success of the organization.

Graduated from the Cork Institute of Technology in Ireland Mr. O’Halloran brings a very unique experience in QA/QC and Regulatory Affairs. For over four years, he worked for a biotechnology company contracted by the US Department of Defense to develop and provide countermeasures for chemical and biological weaponry. David also has several years experience in new product development and has headed the Regulatory Affairs, Quality Assurance and Quality Control Department of a skincare pharmaceutical company. He has been in the cannabis industry for the past 5 years, becoming well versed in Health Canada’s cannabis regulatory framework.

Teresa is a pharmaceutical marketing professional with over 30 years of experience in the healthcare / pharma sectors, including Sandoz Canada, Berlex Canada, Novartis Oncology, Kidney Foundation of Canada, Epilepsy Canada. Her expertise spans Learning and Development consulting for pharmaceutical commercial and marketing operations, specialty brand / franchise management, marketing research management and patient program development. Teresa’s unique combination of marketing research/analytics and brand marketing management expertise will help us uncover insights and apply strategic thinking for sustainable business advantage.